In Short

Cristina Müller, PhD, is a research group leader at the Center for Radiopharmaceutical Sciences at Paul Scherrer Institute and adjunct Professor at the ETH Zurich, Switzerland. Her research focuses on the development and preclinical application of novel radioligands for targeting cancer and inflammatory diseases. A particular interest lies in the investigation of emerging radionuclides for radiotheragnostics.